Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
18.05.21 | Exasol - All systems go | 949 | Edison Investment Research | FY20 was a year of groundwork for Exasol, with the IPO and a later fund raise injecting resources into a previously cash-strapped business. From H220, Exasol started to invest those funds into the business... ► Artikel lesen | |
18.05.21 | 4imprint Group - Upgrade from US reopening progress | 261 | Edison Investment Research | 4imprint's AGM statement indicates improving momentum in its order intake as the US economy reopens. Having lifted our forecast numbers initially in March, we are now raising our FY21 revenue projection... ► Artikel lesen | |
18.05.21 | TXT e-solutions - Strong Q1 drives upgrades | 313 | Edison Investment Research | TXT e-solutions reported strong revenue and profit growth in Q121, reflecting the benefit of recent acquisitions and good cost control. Since the end of Q1, the company has signed promising contracts... ► Artikel lesen | |
18.05.21 | Murray Income Trust - Maintaining a commitment to quality and income | 192 | Edison Investment Research | Murray Income Trust (MUT) invests in a diversified portfolio of mainly UK equities. It focuses on quality stocks and aims to provide a high and growing income, combined with capital growth. MUT's merger... ► Artikel lesen | |
18.05.21 | Acorn Income Fund Limited - Board proposes change of mandate and manager | 202 | Edison Investment Research | The board of Acorn Income Fund (AIF) has announced the results of its strategic review ahead of the company's five-yearly discontinuation vote in August. It is proposing to change the mandate from its... ► Artikel lesen | |
18.05.21 | Newron Pharmaceuticals - Long-term generic challenge to Xadago | 383 | Edison Investment Research | The FDA has notified Newron that an application for a generic safinamide (Xadago) has been filed. Xadago has new chemical entity (NCE) exclusivity until 27 March 2022. Xadago is then protected to December... ► Artikel lesen | |
18.05.21 | CASI Pharmaceuticals - Continuing to execute | 285 | Edison Investment Research | CASI continues to execute on multiple fronts and demonstrates that it has become a multifaceted company. It is expanding the sales of Evomela, its proprietary formulation of melphalan for multiple myeloma... ► Artikel lesen | |
18.05.21 | Treatt - Sweet upgrades | 253 | Edison Investment Research | Treatt has once again demonstrated the strength of its business model, with another excellent set of results, and yet another upgrade to guidance. The performance continues to be testament to the management... ► Artikel lesen | |
18.05.21 | Dentsu Group - Progressive quarterly improvements | 313 | Edison Investment Research | Dentsu's Q1 update shows a third successive quarter of improvement (a reducing decline in organic revenue), with Dentsu Japan down 0.9% on Q120 and Dentsu International 3.5% below prior year. Operating... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 6.297 |
DEUTSCHE BANK | 3.115 |
META PLATFORMS | 2.712 |
NVIDIA | 2.016 |
AIXTRON SE | 1.516 |
TESLA | 1.506 |
MICROSOFT | 1.478 |
BASF | 1.457 |
TUI | 1.428 |
ALPHABET | 1.276 |
SUPER MICRO COMPUTER | 1.242 |
BAYER | 1.165 |
RHEINMETALL | 1.135 |
NEL | 1.018 |
VARTA | 956 |
NEWMONT | 920 |
COMMERZBANK | 831 |
AMAZON | 818 |
BYD | 768 |
RENK GROUP | 768 |
HELLOFRESH | 698 |
PLUG POWER | 685 |
INFINEON | 679 |
IBM | 671 |
VOLKSWAGEN | 554 |